Related Experiment Videos
Mixed connective tissue disease--clinical and immunological profile
Nedumaran1, C P Rajendran, R Porkodi
1Department of Rheumatology, Madras Medical College, Chennai.
The Journal of the Association of Physicians of India
|January 5, 2002
Summary
This study investigated mixed connective tissue disease (MCTD) in rheumatic patients, finding common symptoms like polyarthritis and Raynaud's phenomenon. All patients showed antinuclear and anti-U1RNP antibodies, supporting MCTD as a distinct syndrome.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Mixed Connective Tissue Disease (MCTD) presents a diagnostic challenge due to overlapping features with other systemic autoimmune diseases.
- Understanding the clinical and immunological characteristics of MCTD is crucial for accurate diagnosis and management.
Purpose of the Study:
- To elucidate the clinical manifestations and immunological profile of patients diagnosed with Mixed Connective Tissue Disease (MCTD).
- To identify key diagnostic markers and common symptoms within a rheumatic disease population.
Main Methods:
- Retrospective analysis of 6400 rheumatic disease cases treated between 1996-1999.
- Detailed study of eight cases meeting preliminary diagnostic criteria for MCTD.
- Evaluation of clinical symptoms and immunological markers, including antinuclear antibodies and anti-U1RNP antibodies.
Main Results:
- All eight MCTD cases were female, aged 23-50.
- Common symptoms included polyarthritis, Raynaud's phenomenon, and sclerodactyly (100%).
- Oesophageal abnormalities, pulmonary changes, myositis, and facial erythema were also frequently observed. All patients tested positive for antinuclear and anti-U1RNP antibodies.
Conclusions:
- MCTD should be considered in patients with heterogeneous presentations not fitting established systemic connective tissue disorder criteria.
- The presence of specific autoantibodies (anti-U1RNP) alongside characteristic clinical features aids in diagnosing MCTD.
- Recognizing MCTD as a distinct entity is vital for appropriate patient care and management strategies.